Published in Eur Urol on February 20, 2010
Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis. Int J Clin Pract (2013) 1.61
Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction. Asian J Androl (2015) 1.50
Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group. Arthritis Res Ther (2012) 1.44
Brachial artery flow-mediated dilatation and carotid intima-media thickness in young ED patients with insulin resistance. Int J Impot Res (2016) 1.39
Combination of low-energy shock-wave therapy and bone marrow mesenchymal stem cell transplantation to improve the erectile function of diabetic rats. Asian J Androl (2016) 1.39
Evaluation of the aphrodisiac activity of Tribulus terrestris Linn. in sexually sluggish male albino rats. J Pharmacol Pharmacother (2012) 1.11
Male sexual dysfunction in Asia. Asian J Androl (2011) 1.06
New insights on premature ejaculation: a review of definition, classification, prevalence and treatment. Asian J Androl (2012) 0.97
The future is today: emerging drugs for the treatment of erectile dysfunction. Expert Opin Emerg Drugs (2010) 0.96
Endovascular treatment of vasculogenic erectile dysfunction. Asian J Androl (2015) 0.95
An Update of the International Society of Sexual Medicine's Guidelines for the Diagnosis and Treatment of Premature Ejaculation (PE). Sex Med (2014) 0.94
Lifestyle modifications and erectile dysfunction: what can be expected? Asian J Androl (2015) 0.92
Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews. BMC Fam Pract (2013) 0.92
Safety and efficacy of low intensity shockwave (LISW) treatment in patients with erectile dysfunction. Int Braz J Urol (2015) 0.91
Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction. Asian J Androl (2011) 0.91
Urologist's Practice Patterns Including Surgical Treatment in the Management of Premature Ejaculation: A Korean Nationwide Survey. World J Mens Health (2013) 0.90
Priapism: pathophysiology and the role of the radiologist. Br J Radiol (2012) 0.90
Erectile dysfunction in the elderly: an old widespread issue with novel treatment perspectives. Int J Endocrinol (2014) 0.89
Dapoxetine: a new option in the medical management of premature ejaculation. Ther Adv Urol (2012) 0.88
Current therapeutic strategies for premature ejaculation and future perspectives. Asian J Androl (2011) 0.88
Medical therapy for premature ejaculation. Ther Adv Urol (2011) 0.87
Erectile dysfunction and hypertension: impact on cardiovascular risk and treatment. Int J Hypertens (2012) 0.87
Medical management of erectile dysfunction in aging males: is it too late to treat? Asian J Androl (2013) 0.86
Udenafil for the treatment of erectile dysfunction. Ther Clin Risk Manag (2014) 0.86
On-demand use of tramadol, sildenafil, paroxetine and local anaesthetics for the management of premature ejaculation: A randomised placebo-controlled clinical trial. Arab J Urol (2013) 0.85
The role of the sexual partner in managing erectile dysfunction. Nat Rev Urol (2016) 0.84
Heart Rate Variability in Men with Erectile dysfunction. Int Neurourol J (2011) 0.84
Comparison of alpha blockers in treatment of premature ejaculation: a pilot clinical trial. Iran Red Crescent Med J (2013) 0.84
Effect of an adipose-derived stem cell and nerve growth factor-incorporated hydrogel on recovery of erectile function in a rat model of cavernous nerve injury. Tissue Eng Part A (2012) 0.83
Advances in understanding and treating premature ejaculation. Nat Rev Urol (2015) 0.83
Comparison of paroxetine and dapoxetine, a novel selective serotonin reuptake inhibitor in the treatment of premature ejaculation. Asian J Androl (2014) 0.82
Current Diagnosis and Management of Erectile Dysfunction. Curr Sex Health Rep (2014) 0.82
Analysis of prescriptions of alpha-blockers and phosphodiesterase 5 inhibitors from the urology department and other departments. Int Neurourol J (2011) 0.82
Efficacy and Safety of Tadalafil 5 mg Administered Once Daily in Korean Men with Erectile Dysfunction: A Prospective, Multicenter Study. Korean J Urol (2010) 0.82
Insulin resistance is an independent determinate of ED in young adult men. PLoS One (2013) 0.82
Comparison of the simplified International Index of Erectile Function (IIEF-5) in patients of erectile dysfunction with different pathophysiologies. BMC Urol (2014) 0.81
Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink. PLoS Med (2016) 0.81
Premature ejaculation: do we have effective therapy? Transl Androl Urol (2013) 0.81
Chronic low dosing of phosphodiesterase type 5 inhibitor for erectile dysfunction. Korean J Urol (2012) 0.81
2015 CUA Practice guidelines for erectile dysfunction. Can Urol Assoc J (2015) 0.80
Oral drug treatments in patients with erectile dysfunction and multiple comorbidities: a retrospective observational study. BMJ Open (2014) 0.80
Efficacy of Ashwagandha (Withania somnifera Dunal. Linn.) in the management of psychogenic erectile dysfunction. Ayu (2011) 0.80
Management of erectile dysfunction in hypertension: Tips and tricks. World J Cardiol (2014) 0.80
Systematic review and meta-analysis on phosphodiesterase 5 inhibitors and α-adrenoceptor antagonists used alone or combined for treatment of LUTS due to BPH. Asian J Androl (2015) 0.80
Erectile dysfunction as an initial presentation of diabetes discovered by taking sexual history. BMJ Case Rep (2012) 0.79
Acupuncture for erectile dysfunction: a systematic review protocol. BMJ Open (2015) 0.79
Sexual Dysfunction in Type 2 Diabetes at Diagnosis: Progression over Time and Drug and Non-Drug Correlated Factors. PLoS One (2016) 0.78
Clinical significance and expression of microRNA in diabetic patients with erectile dysfunction. Exp Ther Med (2015) 0.78
The devil is in the details: an analysis of the subtleties between phosphodiesterase inhibitors for erectile dysfunction. Transl Androl Urol (2016) 0.78
What do most erectile dysfunction guidelines have in common? No evidence-based discussion or recommendation of heart-healthy lifestyle changes and/or Panax ginseng. Asian J Androl (2012) 0.78
The role of dapoxetine hydrochloride on-demand for the treatment of men with premature ejaculation. Sci Rep (2014) 0.78
Validation of the International Index of Erectile Function (IIFE) for use in Brazil. Arq Bras Cardiol (2013) 0.78
Chronic high dose intraperitoneal bisphenol A (BPA) induces substantial histological and gene expression alterations in rat penile tissue without impairing erectile function. J Sex Med (2013) 0.78
Population pharmacokinetic analysis to recommend the optimal dose of udenafil in patients with mild and moderate hepatic impairment. Br J Clin Pharmacol (2016) 0.77
Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature Ejaculation. Nephrourol Mon (2016) 0.77
Results from an online survey investigating ED patients' insights and treatment expectations. Int J Impot Res (2015) 0.77
The Effect of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) on Erectile Function: A Systematic Review and Meta-Analysis. PLoS One (2015) 0.77
A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction. Ther Adv Urol (2014) 0.77
Why do general practitioners prescribe antidepressants to their patients? A pilot study. Biopsychosoc Med (2014) 0.77
Erectile dysfunction in chronic kidney disease: From pathophysiology to management. World J Nephrol (2015) 0.77
Tramadol for premature ejaculation: a systematic review and meta-analysis. BMC Urol (2015) 0.77
The role of statins in erectile dysfunction: a systematic review and meta-analysis. Asian J Androl (2014) 0.77
Phosphodiesterase type 5 inhibitors for treating erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia: A comprehensive review. Arab J Urol (2015) 0.77
Udenafil: efficacy and tolerability in the management of erectile dysfunction. Ther Adv Urol (2013) 0.77
A randomized clinical trial investigating treatment choice in Chinese men receiving sildenafil citrate and tadalafil for treating erectile dysfunction. Asian J Androl (2016) 0.77
Immunization associated with erectile dysfunction based on cross-sectional and genetic analyses. PLoS One (2014) 0.76
Avanafil for erectile dysfunction in elderly and younger adults: differential pharmacology and clinical utility. Ther Clin Risk Manag (2014) 0.76
Shortened penis post penile prosthesis implantation treated with subcutaneous soft silicone penile implant: case report. Int J Impot Res (2013) 0.76
An analysis of treatment preferences and sexual quality of life outcomes in female partners of Chinese men with erectile dysfunction. Asian J Androl (2016) 0.76
Evolving therapeutic strategies for premature ejaculation: The search for on-demand treatment - topical versus systemic. Can Urol Assoc J (2012) 0.76
Erectile dysfunction. Nat Rev Dis Prim (2016) 0.76
Anxiety and depression among Greek men with primary erectile dysfunction and premature ejaculation. Ann Gen Psychiatry (2015) 0.76
Efficacy and safety of local anaesthetics for premature ejaculation: a systematic review and meta-analysis. Asian J Androl (2013) 0.76
Assessment of sexual functions in partners of women with complaints of urinary incontinence. Int Braz J Urol (2016) 0.75
Pharmaco-induced erections for penile color-Doppler ultrasound: oral pde5 inhibitors or intracavernosal injection? Int J Impot Res (2014) 0.75
The Effects of Adipose-Derived Stem Cells in a Rat Model of Tobacco-Associated Erectile Dysfunction. PLoS One (2016) 0.75
Rhodiola rosea, folic acid, zinc and biotin (EndEP(®)) is able to improve ejaculatory control in patients affected by lifelong premature ejaculation: Results from a phase I-II study. Exp Ther Med (2016) 0.75
Difference of opinion - Inflatable Penile Prosthesis - Opinion: Why I prefer the infrapubic access. Int Braz J Urol (2015) 0.75
Additive effects of Artemisia capillaris extract and scopoletin on the relaxation of penile corpus cavernosum smooth muscle. Int J Impot Res (2015) 0.75
Biallelic and Triallelic 5-Hydroxytyramine Transporter Gene-Linked Polymorphic Region (5- HTTLPR) Polymorphisms and Their Relationship with Lifelong Premature Ejaculation: A Case-Control Study in a Chinese Population. Med Sci Monit (2016) 0.75
Erectile dysfunction: a window to the heart. BMJ Case Rep (2015) 0.75
Acromegaly Presenting as Erectile Dysfunction: Case Reports and Review of the Literature. Rev Urol (2015) 0.75
The impact of ejaculatory dysfunction upon the sufferer and his partner. Transl Androl Urol (2016) 0.75
Is there a place for surgical treatment of premature ejaculation? Transl Androl Urol (2016) 0.75
Treatment expectations of men with ED and their female partners: an exploratory qualitative study based on grounded theory. Int J Impot Res (2015) 0.75
A review of the efficacy and safety of mirodenafil in the management of erectile dysfunction. Ther Adv Urol (2016) 0.75
Comparison of the efficacy and safety of 5-mg once-daily versus 5-mg alternate-day tadalafil in men with erectile dysfunction and lower urinary tract symptoms. Int J Impot Res (2014) 0.75
Dissatisfaction with male sexual performance and female sexual dysfunction in women with type 1 diabetes. Int J Impot Res (2014) 0.75
Trends in the placement of penile prostheses over the last 17 years in France. Asian J Androl (2015) 0.75
Pharmacokinetic interaction between udenafil and dapoxetine: a randomized, open-labeled crossover study in healthy male volunteers. Drug Des Devel Ther (2015) 0.75
Sexual dysfunction in 2013: Advances in epidemiology, diagnosis and treatment. Arab J Urol (2013) 0.75
Association of STin2 VNTR Polymorphism of Serotonin Transporter Gene with Lifelong Premature Ejaculation: A Case-Control Study in Han Chinese Subjects. Med Sci Monit (2016) 0.75
Management of end-stage erectile dysfunction and stress urinary incontinence after radical prostatectomy by simultaneous dual implantation using a single trans-scrotal incision: surgical technique and outcomes. Asian J Androl (2015) 0.75
The impact of metabolic syndrome on retinal findings in patients with erectile dysfunction. Turk J Urol (2013) 0.75
Erectile Dysfunction in Individuals with Neurologic Disability: A Hospital-based Cross-sectional Study. Innov Clin Neurosci (2016) 0.75
The role of phosphodiesterase type-5 inhibitors in treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia. Turk J Urol (2013) 0.75
The impact of surgical treatments for lower urinary tract symptoms/benign prostatic hyperplasia on male erectile function: A systematic review and network meta-analysis. Medicine (Baltimore) (2016) 0.75
Psychosocial outcomes after initial treatment of erectile dysfunction with tadalafil once daily, tadalafil on demand or sildenafil citrate on demand: results from a randomized, open-label study. Int J Impot Res (2014) 0.75
Comparative evaluation of the aphrodisiac efficacy of sildenafil and Carpolobia lutea root extract in male rabbits. J Intercult Ethnopharmacol (2015) 0.75
Effect of dutasteride on the risk of prostate cancer. N Engl J Med (2010) 12.78
EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol (2013) 7.48
EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol (2010) 7.20
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol (2013) 6.54
EAU guidelines on prostate cancer. Eur Urol (2007) 6.30
EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol (2013) 4.89
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol (2013) 4.65
EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol (2013) 4.58
Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol (2009) 4.58
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol (2007) 4.37
2007 Guideline for the management of ureteral calculi. Eur Urol (2007) 3.98
Pelvic lymph node dissection in prostate cancer. Eur Urol (2009) 3.93
EAU guidelines on penile cancer: 2014 update. Eur Urol (2014) 3.86
The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol (2009) 3.31
Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol (2003) 3.31
Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol (2012) 3.26
Assessing the impact of ischaemia time during partial nephrectomy. Eur Urol (2009) 3.18
A non-cancer-related survival benefit is associated with partial nephrectomy. Eur Urol (2011) 3.18
Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis. Int J Urol (2012) 3.17
Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol (2009) 3.14
The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients. Int J Radiat Oncol Biol Phys (2010) 3.06
Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: results from the nationwide inpatient sample. Eur Urol (2011) 3.03
Insignificant prostate cancer and active surveillance: from definition to clinical implications. Eur Urol (2009) 2.97
European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol (2013) 2.93
Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J (2006) 2.91
Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol (2010) 2.82
Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. Urology (2011) 2.76
Downsides of robot-assisted laparoscopic radical prostatectomy: limitations and complications. Eur Urol (2009) 2.76
Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy. Eur Urol (2012) 2.74
Effect of sildenafil on middle-aged sexually active males with no erectile complaints: a randomized placebo-controlled double-blind study. Eur Urol (2008) 2.74
A plea for integrating laparoscopy and robotic surgery in everyday urology: the rules of the game. Eur Urol (2007) 2.68
Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur Urol (2011) 2.63
Low-intensity extracorporeal shock wave therapy--a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy. J Sex Med (2011) 2.63
Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur Urol (2009) 2.55
Indications for pelvic nodal treatment in prostate cancer should change. Validation of the Roach formula in a large extended nodal dissection series. Int J Radiat Oncol Biol Phys (2011) 2.55
Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol (2012) 2.55
Head-to-head comparison of prostate health index and urinary PCA3 for predicting cancer at initial or repeat biopsy. J Urol (2013) 2.48
Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. Eur Urol (2012) 2.46
Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis. Eur Urol (2012) 2.45
Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol (2012) 2.43
Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol (2009) 2.41
European Association of Urology guidelines on priapism. Eur Urol (2013) 2.41
EAU guidelines on penile curvature. Eur Urol (2012) 2.40
Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. Eur Urol (2010) 2.38
Apoptosis and effects of intracavernous bone marrow cell injection in a rat model of postprostatectomy erectile dysfunction. Eur Urol (2008) 2.38
Cystic nephroma and mixed epithelial and stromal tumour of the kidney: opposite ends of the spectrum of the same entity? Eur Urol (2007) 2.33
Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB). BJU Int (2012) 2.31
Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol (2010) 2.30
The contemporary concept of significant versus insignificant prostate cancer. Eur Urol (2011) 2.29
Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis. Eur Urol (2011) 2.29
Laparoendoscopic single-site and natural orifice transluminal endoscopic surgery in urology: a critical analysis of the literature. Eur Urol (2010) 2.28
BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial. Eur Urol (2005) 2.26
Topical prilocaine-lidocaine cream combined with peripheral nerve block improves pain control in prostatic biopsy: results from a prospective randomized trial. Eur Urol (2007) 2.24
Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series. Eur Urol (2011) 2.20
Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy. Urology (2011) 2.20
Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients. Eur Urol (2008) 2.20
Bulbar urethroplasty using buccal mucosa grafts placed on the ventral, dorsal or lateral surface of the urethra: are results affected by the surgical technique? J Urol (2005) 2.19
Immunoglobulin G4-related disease in genitourinary organs: an emerging fibroinflammatory entity often misdiagnosed preoperatively as cancer. Eur Urol (2012) 2.18
Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer. Urology (2009) 2.17
Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics (2003) 2.17
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy. Eur Urol (2007) 2.16
Oncologic results of laparoscopic renal cryoablation for clinical T1a tumors: 8 years of experience in a single institution. Urology (2010) 2.15
A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006. Eur Urol (2010) 2.13
Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response study. Am J Psychiatry (2006) 2.13
Guidelines on Testicular Cancer: 2015 Update. Eur Urol (2015) 2.11
Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities. BJU Int (2012) 2.10
Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer. Int J Urol (2012) 2.08
Peyronie's disease and autoimmunity—a real-life clinical study and comprehensive review. J Sex Med (2015) 2.08
Pelvic lymph node dissection for prostate cancer: adherence and accuracy of the recent guidelines. Int J Urol (2012) 2.08
Early radiotherapy after radical prostatectomy improves cancer-specific survival only in patients with highly aggressive prostate cancer: validation of recently released criteria. Int J Urol (2014) 2.08
High-risk prostate cancer: from definition to contemporary management. Eur Urol (2012) 2.06
Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissection. J Urol (2010) 2.05
EAU guidelines on surgical treatment of urinary incontinence. Eur Urol (2012) 2.05
Will focal therapy remain only an attractive illusion for the primary treatment of prostate cancer? J Clin Oncol (2014) 2.05
The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin (2004) 2.03
High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer. Eur Urol (2007) 2.02
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol (2006) 2.02
Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension. Eur Urol (2010) 1.99
Critical assessment of the European Association of Urology guideline indications for pelvic lymph node dissection at radical prostatectomy. BJU Int (2011) 1.99
The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). BJU Int (2013) 1.99
Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur Urol (2008) 1.98
EAU guidelines on chronic pelvic pain. Eur Urol (2009) 1.97
Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol (2006) 1.96
EAU guidelines on testicular cancer: 2011 update. Eur Urol (2011) 1.96